Global Advanced Research Journal of Medicine and Medical Sciences (GARJMMS) ISSN: 2315-5159
March 2016 Issue Vol. 5(3), pp. 088-095
Copyright © 2016 Global Advanced Research Journals
Full Length Research Paper
Therapeutic effect of Phoenix dactylifera against cryptosporidiosis in immunocompromised mice
Naksheen Merza Mahmood1,2*, Nadia Farid Ramadan2, Shadia Mohamed Hassan2, HodaYaaqob Sabry3 and Mona Mohamed Magdy4
1Biology Department, College of Science for Woman, University of Baghdad, Baghdad, Iraq
2Zoology Department, College of Science, Ain Shams University, Cairo, Egypt
3Parasitology Department, Theodor Bilharz Research Institute, Imbaba 0200, Egypt
4Pathology Department, Theodor Bilharz Research Institute, Imbaba 0200, Egypt
*Corresponding Author E-mail: naksheen_ardalan@yahoo.com
Accepted 24 March, 2016
Abstract
Cryptosporidium infection can cause severe consequences in immunodeficient hosts, yet no effective drug therapy has been approved till now. Thus, it is increasingly necessary for evaluating new potential drugs against Cryptosporidium in immunocompromised patients. The strain of Cryptosporidium was identified using nested PCR and revealed C. parvum. The present work was carried out to evaluate the effect of aqueous extract of Phoenix dactylifera fruits against C. parvum in immunosuppressed mice. Then, the anticryptosporidial and anti-inflammatory effects were studied through evaluation of oocyst output, immunological parameter (INF-γ and IL-10). Very high statistically significant (p< 0.001) were seen post treatment with P.dactylifera, the percentage reduction of oocysts in feaces was 88.21%. Both cytokines INF-γ and IL-10 were increased before and after treatment with P.dactylifera when compared to control normal mice. Histopathological and electron microscopic examination revealed complete healing of intestinal mucosa after 21 days of treatment. Conclusion: Phoenix dactylifera is a promising anticryptosporidial global treatment without side effects on immunosuppressed host.
Keywords: Phoenix dactylifera, Cryptosporidiumparvum, IL-10, IFN-γ, immunosuppressed.